The review by Beccano-Kelly summarizes the body of knowledge around leptin as a potential treatment for AD since dysfunctions in the leptin system have recently been linked to neurodegenerative disorders such as Alzheimer's disease. This evidence concerns the gene LEP and Alzheimer disease.